In our latest Pharma Explained we look explore what Monkeypox is, how it impacts the body, and the larger-scale issues associated with the disease.
Related Posts
![](https://pharmaceuticalmanufacturer.media/downloads/11153/download/shutterstock_1965946939%20(2).jpg?cb=f4aa2a0eee8ac9a990a97fe1b98eb5ab&w=1200)
FDA Approves Roche’s Alecensa – European Pharmaceutical Manufacturer
Roche have announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment following tumour resection…
![](https://pharmaceuticalmanufacturer.media/downloads/11321/download/shutterstock_1036394266.jpg?cb=a5cfc8ae3f98536d20d7c7371663eec7&w=1200)
Sage Therapeutics Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s Disease
Sage Therapeutics announced topline results from the Phase 2 SURVEYOR Study. The study met its primary endpoint demonstrating a statistically significant…
![](https://pharmaceuticalmanufacturer.media/downloads/10806/download/Screen%20Shot%202024-01-16%20at%2010.59.53.png?cb=b73c80e4923aab5af9f2826aa4cba084&w=1200)
CME Automation Systems’ New Modular Automation System PACE
A new modular automation system for clinical trials drug delivery – now in operation at the Medical Manufacturing Innovation Centre…